Melanoma Institute Australia

This study is testing whether a less extensive lymph node surgery is as effective as the standard, more extensive surgery for people with stage III melanoma who have already received immunotherapy. After 6 weeks of immunotherapy drugs, participants will be randomly assigned to ha…

This trial is testing whether giving two immunotherapy drugs before surgery can help people with a rare and aggressive skin cancer called Merkel cell carcinoma. The goal is to shrink the tumor and lower the chance of the cancer coming back after surgery. About 20 participants wit…

This trial is testing new combinations of immunotherapy drugs given before surgery for patients with advanced melanoma that can be surgically removed. The study focuses on patients who are predicted to respond poorly to standard immunotherapy or whose melanoma has returned despit…

This study is testing if combining two standard cancer treatments works better than one alone for advanced melanoma that has spread to a few places in the body. It will compare standard immunotherapy drugs, which help the body's immune system fight cancer, to those same drugs plu…

This study is testing if adding a precise form of brain radiation to a two-drug immunotherapy combination works better than the immunotherapy alone. It is for adults with melanoma skin cancer that has spread to the brain but is not yet causing symptoms. The main goal is to see if…

This study is testing whether giving two immunotherapy drugs before surgery can better shrink advanced skin cancer tumors and help prevent the cancer from coming back. It will involve 20 adults with a type of skin cancer called cutaneous squamous cell carcinoma that is advanced b…

This study is testing a new predictive tool to see if it can accurately forecast which patients with melanoma and other cancers will respond to immunotherapy treatments. It will enroll 1,000 patients who are eligible for standard immunotherapy. The goal is to see if this tool can…